TRAX
TRAX
US3371851029
First Tracks Biotherapeutics, I
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Market & Enterprise Value
Market Cap
1.14B EUR
712.06M EUR
Enterprise Value
974.34M EUR
548.38M EUR
Valuation Multiples
Trailing P/E
--
--
Forward P/E
-8.89x
--
Price to Sales
--
--
Price to Book
6.68x
4.22x
EV/Revenue
--
--
EV/EBITDA
-5.76x
--
Price to FCF (P/FCF)
--
--
EV/FCF
--
--
FCF Yield
--
-20.82%
ende